1-7 of 7
Andrew Hsu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Platelet Count and Mean Platelet Volume with Severity of Bleeding Events in Patients with Immune Thrombocytopenia

Sovijja Pou, Charmi Trivedi, Charles Milrod, Christina Raker, Andrew Hsu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1177.
https://doi.org/10.1182/blood-2024-204425
Published: 2024
Journal Articles

Predictive Factors and Outcomes for Ibrutinib Therapy in Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter Cohort Study

Narendranath Epperla, MDMS, Qiuhong Zhao, MS, Sayan Mullick Chowdhury, PhD, Tamara K. Moyo, MD, Lauren Shea, MD, Nishitha Reddy, MD MSCI, Julia Sheets, MD, David M. Weiner, BA, Praveen Ramakrishnan Geethakumari, MD MS, Malathi Kandarpa, PhD, Ximena JordanBruno, MD, Colin Thomas, MD, Michael C. Churnetski, Andrew Hsu, MD, Joseph Maakaron, MD, Paolo Caimi, MD, Pallawi Torka, MD, Celeste Bello, MD, Cherie Tan, MD, Kevin A. David, MD, Kathryn Lindsey, MD, Irl Brian Greenwell, MD, Murali Janakiram, MD, Adam J Olszewski, MD, Jonathon B. Cohen, MDMS, Neil Palmisiano, MDMS, Elvira Umyarova, MD, Ryan A. Wilcox, MD, Farrukh T Awan, MD, Stefan K. Barta, MDMRCP,MS, Natalie S Grover, MD, Nancy L. Bartlett, MD, Yazeed Sawalha, MD, Beth A. Christian, MD, Alex F. Herrera, MD, Geoffrey Shouse, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-135870
Published: 2020
Journal Articles

CD5 Expression in Marginal Zone Lymphoma (MZL) Predicts Worse Outcomes with Rituximab (R) but Not with Bendamustine/Rituximab (BR)

Andrew Hsu, MD, Adam Zayac, MD, Habibe Kurt, MD, Adam J Olszewski, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 50–51.
https://doi.org/10.1182/blood-2020-134498
Published: 2020
Journal Articles

Cerebrospinal Fluid (CSF) Analysis of Tumor-Specific Cell-Free DNA (cfDNA) As a Diagnostic and Prognostic Tool for Central Nervous System (CNS) Invasion in Lymphoma

Adam J Olszewski, MD, Anna D Chorzalska, PhD, Max Petersen, Thomas A Ollila, MD, Adam Zayac, MD, Habibe Kurt, MD, Diana O Treaba, MD, John L Reagan, MD, Andrew Hsu, MD, Pamela C Egan, MD, James Butera, MD, William Rafelson, MDMBA, Rabin Niroula, MBBS, John Vatkevich, Jordan Robison, CRA, Ilyas Sahin, MD, Chelsea D Mullins, BS, Patrycja M Dubielecka, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-134757
Published: 2020
Journal Articles

The fertile field of “isomopic” immune dysregulation as a nidus for lymphoproliferative disorders

Andrew Hsu, Nancy Freeman
Journal: Blood
Blood (2020) 135 (15): 1303.
https://doi.org/10.1182/blood.2019004629
Published: 2020
Journal Articles

Verruconis gallopava in a patient with myelofibrosis on ruxolitinib

Andrew Hsu, Veronica Ulici
Journal: Blood
Blood (2020) 135 (14): 1189.
https://doi.org/10.1182/blood.2020004799
Published: 2020
Journal Articles

Survival Benefits from Antifungal Prophylaxis and a Dedicated Inpatient Malignant Hematology Service during Induction Chemotherapy for Acute Myeloid Leukemia

Andrew Hsu, MD, Robert Matera, MD, John L. Reagan, MD, Dimitrios Farmakiotis, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3436.
https://doi.org/10.1182/blood-2019-122264
Published: 2019